← Back to headlines
Axogen Projects $270M Revenue by 2026 Amid Biologic Channel Transition
Axogen has outlined a revenue target of at least $270 million by 2026, anticipating at least 20% growth as it transitions its Avance biologic channel.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
